CEFOXITIN - INTRAVENOUS PHARMACOKINETICS AND INTRAMUSCULAR BIOAVAILABILITY IN KWASHIORKOR

被引：9

作者：

BUCHANAN, N

MITHAL, Y

WITCOMB, M

机构：

[1] BARAGWANATH HOSP,DEPT PAEDIAT,METAB & NUTR RES UNIT,JOHANNESBURG 2013,SOUTH AFRICA

[2] BARAGWANATH HOSP,S AFRICAN INST MED RES,DEPT MICROBIOL,JOHANNESBURG 2013,SOUTH AFRICA

来源：

关键词：

D O I：

10.1111/j.1365-2125.1980.tb01093.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：623 / 627

页数：5

共 9 条

[1] ALLEYNE GAO, 1967, PEDIATRICS, V39, P400
[2] CEFOXITIN - REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE
BROGDEN, RN
HEEL, RC
SPEIGHT, TM
AVERY, GS
[J]. DRUGS, 1979, 17 (01) : 1 - 37
[3] PENICILLIN PHARMACOKINETICS IN KWASHIORKOR
BUCHANAN, N
ROBINSON, R
KOORNHOF, HJ
EYBERG, C
[J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 1979, 32 (11) : 2233 - 2236
[4] GENTAMICIN PHARMACOKINETICS IN KWASHIORKOR
BUCHANAN, N
DAVIS, MD
EYBERG, C
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (05) : 451 - 453
[5] PHARMACOKINETICS OF CEFOXITIN SODIUM IN NORMAL SUBJECTS AND IN UREMIC PATIENTS
FILLASTRE, JP
LEROY, A
GODIN, M
OKSENHENDLER, G
HUMBERT, G
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1978, 4 : 79 - 83
[6] LUI C, 1979, REV INFECTIOUS DIS, V1, P127
[7] BIOAVAILABILITY AND PHARMACOKINETICS OF CEFOXITIN SODIUM
SCHROGIE, JJ
DAVIES, RO
YEH, KC
ROGERS, D
HOLMES, GI
SKEGGS, H
MARTIN, CM
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1978, 4 : 69 - 78
[8] SCRAGG JN, 1978, S AFR MED J, V53, P358
[9] 1971, WHO477 TECHN REP SER